A biotech company in the Tampa Bay area is developing a cancer vaccine.
The company has received encouragement from the FDA to start testing the treatment on humans later this year at the University of Nebraska.
CFO Joe Scanlon from Morphogenesis tells Newsradio 970 WFLA's AM Tampa Bay how the vaccine works. Listen below...
File Photo Credit Getty Images